Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and

Tilray reported Q1-2027 financial results last week with increasing revenue from its BrewDog operati

Tilray reported disappointing fiscal Q1 results, missing revenue estimates despite management highli

Tilray's cash burn continues to be a big problem for investors. The business has been growing throug

Canopy Growth is refining its focus on medical and adult-use markets while managing its U.S. expansi

Tilray's financial results have been weak for years. The company operates in an uncertain industry.

Canaccord Genuity analyst Kenric Tyghe maintains Tilray Brands (NASDAQ:TLRY) with a Hold and lowe

Tilray Brands TodayTLRYTilray Brands$3.44 -0.15 (-4.04%) As of 11:26 AM Eastern This is a fair marke

Tilray Brands, Inc. (TLRY) Q1 2027 Earnings Call Transcript

Tilray Brands NASDAQ: TLRY reported record first-quarter revenue and gross profit, driven by its Bre

Tilray Inc (NASDAQ:TLRY), the cannabis and consumer products company, reported record first-quarter

Tilray Brands Inc. (NASDAQ:TLRY) reported a first-quarter 2027 adjusted loss of 2 cents per share on

A Q1 FY2027 revenue record from Tilray Brands (NASDAQ:TLRY) is drawing heavy selling, because the se

Tilray Brands (NASDAQ:TLRY) reported first-quarter financial results on Thursday. The transcript fro

Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.32 per share versus the Zacks Consen

Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss

Tilray Brands (NASDAQ:TLRY) reported quarterly losses of $(0.02) per share which beat the analyst co

Tilray Brands (TSX:TLRY) reported quarterly losses of $(0.02) per share which beat the analyst conse

First-Quarter Results Reinforce Tilray's Progress Converting Global Scale, Disciplined Execution and

Stocks in focus: Applied Digital beat Q1 estimates; Levi posted mixed results. Investors await earni

Market sentiment slipped but stayed neutral as U.S. stocks fell amid rising Treasury yields; mortgag

Will S&P 500 open higher? Polymarket odds sit at 52% as Wall Street weighs 5.35% Treasury yields

Tilray Brands (TLRY) has been in a strong downtrend and is now trading near its all-time low. The st

Hazy Jane Tropical and Krush Test Dummy take Gold as BrewDog builds on its recent sweep at the 2026

Bold UK-wide campaign puts craft beer back at the centre of culture, celebrating better ingredients,

The multi-year cannabis sector bear market is starting to give way to a calculated wave of industry

Tilray doesn't have appealing growth prospects, despite diversifying into beverages in recent years.

Earnings season is set to bring heightened volatility, with PepsiCo, Constellation Brands, Delta Air

https://www.marijuanamoment.net/dea-judge-pauses-marijuana-rescheduling-hearing-as-opponents-highlig

Tilray has increased annual cultivation capacity at its Quebec facility by 30 metric tonnes, materia

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Tilray Brands shares jumped 2.23% after hours as quarterly revenue beat estimates, despite earnings

Tilray Brands (TSX:TLRY) reported quarterly earnings of $0.05 per share which beat the analyst conse

TD Cowen analyst Robert Moskow maintains Tilray Brands (NASDAQ:TLRY) with a Buy and lowers the pr

Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a leading global medic

Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) ("Tilray"), a global leader in medical cannabis,

https://www.benzinga.com/markets/equities/26/06/53113507/trump-says-iran-took-too-long-and-will-pay-

The introduction of ARX marks a significant step forward in the quality of medical cannabis availabl

https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amend

https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec

Akanda Corp. (NASDAQ: AKAN) stock surges over 50% Wednesday. Learn how DOJ regulatory shifts and low

Akanda stock surges as U.S. moves to reclassify marijuana, lifting cannabis stocks and fueling stron

Tilray Brands eyes U.S. expansion as cannabis reclassification to Schedule III creates new opportuni

SoFi Technologies faces volatility ahead of April 29 earnings. Read our technical breakdown, key sup

https://apnews.com/article/medical-marijuana-rescheduling-justice-department-trump-cannabis-1d6722d3

Akanda Corp. shares jump 33.69% after hours following a 214% intraday surge.

Cannabis ETFs surge as Trump signals Schedule III reclassification, boosting profit outlook and inve

Trump is reportedly set to reclassify marijuana this week, but Polymarket traders put the odds at ju

Shares of Tilray Brands (NASDAQ: TLRY) are trading higher Wednesday afternoon following breaking new

https://www.axios.com/2026/04/22/trump-marijuana-rule-change